Monoclonal Antibody PAL-M1 Recognizes the Transferrin Receptor and Is a Progression Marker in Melanocytic Lesions
- 1 July 1990
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 95 (1) , 65-69
- https://doi.org/10.1111/1523-1747.ep12873947
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Monoclonal Antibodies Selected to Discriminate Between Malignant Melanomas and Nevocellular NeviJournal of Investigative Dermatology, 1985
- A tumor-associated antigen expressed in melanoma cells with lower malignant potentialInternational Journal of Cancer, 1985
- In situ analysis of antigens on malignant and benign cells of the melanocyte lineage. Differential expression of two surface molecules, gp75 and p89.The Journal of Experimental Medicine, 1985
- Immunohistological study of transferrin receptor expression in non‐Hodgkin's lymphomaBritish Journal of Haematology, 1984
- Transferrin receptor and B-lymphoblast antigen — their relationship to DNA synthesis, histology and survival in B-cell lymphomasInternational Journal of Cancer, 1984
- Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue originEuropean Journal of Immunology, 1981
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979
- Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysisCell, 1978
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- ENZYME-LABELED ANTIBODIES: PREPARATION AND APPLICATION FOR THE LOCALIZATION OF ANTIGENSJournal of Histochemistry & Cytochemistry, 1966